Implementer: Médecins Sans Frontières
Site: National Tuberculosis Control Centre, Abovian (Yerevan) and multiple TB facilities situated throughout the country
Tuberculosis re-emerged in Armenia after the country’s independence in 1991. It has since become a significant public health problem. The country’s tuberculosis burden remains high, with an estimated incidence rate in 2015 of 41 new tuberculosis cases per 100,000 (WHO, Global Tuberculosis Report 2016).
MDR-TB and XDR-TB are serious problems for the country. According to the latest WHO report, the prevalence of MDR-TB in 2015 was estimated to be 11% among new cases and 47% among the previously treated cases.
Armenia was one of the first countries to respond to the challenge of treating XDR-TB patients, by implementing a compassionate use program for access to Bedaquiline and then Delamanid, allowing patients in need, early access with promising preliminary results.